541-555 of 837
Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
Project Oncology®Higher Risk, Lowered Age: New Colorectal Cancer Screening Guidelines
What to Know About a State-of-the-Art Approach to GIST Treatment
Medical Breakthroughs from Penn MedicineWhat to Know About a State-of-the-Art Approach to GIST Treatment
FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
Project Oncology®FDA D.I.S.C.O.: First Biosimilar Approval for the Treatment of Cancer
CAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
Medical Breakthroughs from Penn MedicineCAR-T Cell Therapy: A Breakthrough Treatment for Fighting Cancer
Rethinking Nicotine: The Campaign to Break the World's Tobacco Habit
Primary Care TodayRethinking Nicotine: The Campaign to Break the World's Tobacco Habit
- advertisement
FDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
FDA Drug Information UpdatesFDA D.I.S.C.O.: L-Glutamine for Sickle Cell Disease
Pancreatic Cancer: The Hunt to Catch a Silent Killer
Project Oncology®Pancreatic Cancer: The Hunt to Catch a Silent Killer
FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
Project Oncology®FDA D.I.S.C.O.: Osimertinib for Non-Small Cell Lung Cancer
FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
Project Oncology®FDA D.I.S.C.O.: Two Approvals for ALK-Positive Non-Small Cell Lung Cancer
The CAM Guide to Cancer: An Integrative Approach to Prevention, Treatment, and Healing
NutritionEdgeThe CAM Guide to Cancer: An Integrative Approach to Prevention, Treatment, and Healing
- advertisement
Knowing your Patient's Melanoma Risk Factors
Everyday Family MedicineKnowing your Patient's Melanoma Risk Factors
Linking p53 Variation to Breast Cancer Risk in African American Women
Project Oncology®Linking p53 Variation to Breast Cancer Risk in African American Women
FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
Project Oncology®FDA D.I.S.C.O.: First Tissue/Site Agnostic Cancer Treatment Approval
